Due to the COVID-19 pandemic, the ACP office is closed to the public as our staff work remotely. Click here to see how this impacts our programs and operations.

2020 TPP Alberta Opioid and Benzodiazepine Atlas is now available

November 10, 2021

Produced annually, the atlas provides an overview of TPP-monitored medication use across Alberta.

The purpose of the Tracked Prescription Program (TPP) Alberta Prescription Drug Monitoring Program Atlas is to provide an overview of provincial TPP Alberta medication use for the year 2020. As with the 2019 Atlas, provincial use will be summarized for two classes of medications: opioids (including codeine containing and tramadol-containing medications) and benzodiazepines (BDZ/Z), which include “Z” drugs such as zopiclone, eszopiclone, and zolpidem.

New additions to this year’s atlas include

  • an executive summary,
  • prescribing rate comparisons by socio-economic status,
  • the impact of COVID-19 on prescribing trends,
  • an expanded exploration of trends for the top five geographic areas with the highest rates,
  • an exploration of dosage by specialty group, and
  • brief discussions of some observed prescribing patterns.

Here is some additional information to consider when referring to the atlas:

For more information, visit the TPP Alberta website.

← Previous ArticleNext Article →